XETRA - Delayed Quote EUR

Novavax, Inc. (NVV1.DE)

7.85
-0.04
(-0.53%)
As of February 17 at 5:35:45 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,214,641
682,162
556,382
1,598,951
197,581
Cost of Revenue
157,645
202,739
343,768
902,639
0
Gross Profit
1,056,996
479,423
212,614
696,312
197,581
Operating Expense
645,583
728,354
779,125
1,341,048
1,884,157
Operating Income
411,413
-248,931
-566,511
-644,736
-1,686,576
Net Non Operating Interest Income Expense
-21,687
-20,075
-14,416
-19,880
-21,127
Other Income Expense
98,793
92,391
37,896
10,969
-6,833
Pretax Income
488,519
-176,615
-543,031
-653,647
-1,714,536
Tax Provision
9,822
10,884
2,031
4,292
29,215
Net Income Common Stockholders
478,697
-187,499
-545,062
-657,939
-1,743,751
Diluted NI Available to Com Stockholders
481,331
-187,499
-545,062
-657,939
-1,743,751
Basic EPS
3.04
-1.23
-5.41
-8.42
-23.44
Diluted EPS
2.75
-1.23
-5.41
-8.42
-23.44
Basic Average Shares
157,473.25
152,190
100,768
78,183
74,400
Diluted Average Shares
161,617.25
152,190
100,768
78,183
74,400
Total Operating Income as Reported
411,413
-248,931
-566,511
-644,736
-1,686,576
Total Expenses
803,228
931,093
1,122,893
2,243,687
1,884,157
Net Income from Continuing & Discontinued Operation
478,697
-187,499
-545,062
-657,939
-1,743,751
Normalized Income
427,792.47
-228,538.71
-545,062
-657,939
-1,743,751
Interest Expense
21,687
20,075
14,416
19,880
21,127
Net Interest Income
-21,687
-20,075
-14,416
-19,880
-21,127
EBIT
510,206
-156,540
-528,615
-633,767
-1,693,409
EBITDA
554,895
-108,044
-487,390
-604,713
-1,680,748
Reconciled Cost of Revenue
157,645
202,739
343,768
902,639
0
Reconciled Depreciation
44,689
48,496
41,225
29,054
12,661
Net Income from Continuing Operation Net Minority Interest
478,697
-187,499
-545,062
-657,939
-1,743,751
Total Unusual Items Excluding Goodwill
51,949
51,949
0
0
1,364
Total Unusual Items
51,949
51,949
0
0
1,364
Normalized EBITDA
502,946
-159,993
-487,390
-604,713
-1,680,748
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
1,044.47
10,909.29
0
0
0
12/31/2021 - 1/20/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7V0.DE Darwin AG
28.20
0.00%
 
BIO.DE Biotest Aktiengesellschaft
42.60
0.00%
 
88Q.DE 4basebio PLC
13.00
0.00%
 
9VC.DE Atai Life Sciences N.V.
1.2630
0.00%
 
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
 
AYJ.DE Valneva SE
2.8900
-1.03%
 
VX1.DE Vertex Pharmaceuticals Incorporated
375.75
+0.78%
 
NP5.DE Newron Pharmaceuticals S.p.A.
8.84
0.00%
 
HPHA.DE Heidelberg Pharma AG
3.3000
+5.77%
 
BBZA.DE BB Biotech AG Ord
30.00
-0.50%